9 / 182
OUR
ORGANISATIONAL
STRUCTURE
* Consists of 19 entities
Trusts and structured entities
AdBEE (RF) Ltd
Ad-Izinyosi
(Pty) Ltd
Mpho ea
BopheloTrust
Adcock
IngramHoldings
Limited Employee
ShareTrust
(2008)
Owner
driver
companies*
Thembalami
Pharmaceuticals
(Pty) Ltd
50
%
Adcock
Ingram
Healthcare
(Pty) Ltd
100
%
Addclin
Research (Pty)
Ltd
100
%
Adcock Ingram
Ltd (India)
49,9
%
Tender
Loving
Care–Hygienic,
CosmeticandBaby
CareProducts
(Pty)Ltd
100
%
Adcock
Ingram Critical
Care
(Pty) Ltd
100
%
National Renal
Care (Pty) Ltd
50
%
Adcock
Ingram
(Namibia) (Pty)
Ltd
100
%
Dilwed
Investments
(Pty) Ltd
100
%
Pharmalabs
(Jersey) Ltd
100
%
Novartis
Ophthalmics
(Pty) Ltd
49
%
Menarini SA
(Pty) Ltd
49
%
Adcock
Ingram Ltd
100
%
Adcock
Ingram
Pharmaceuticals
(Pty) Ltd
100
%
Premier
Pharmaceutical
Company (Pty) Ltd
100
%
Metamorphosa
(Pty) Ltd
50
%
Adcock
Ingram
Intellectual
Property (Pty)
Ltd
100
%
Datlabs
(Private) Ltd
100
%
Adcock
Ingram
Intellectual
Property No 1
(Pty) Ltd
100
%
Adcock
Ingram
International
(Pty) Ltd
100
%
Adcock
Ingram
East Africa Ltd
(Kenya)
49
%
51
%
Adcock
Ingram
Healthcare
Private Ltd
(India)
10
%
90
%
Ayrton
Drug
Manufacturing
Ltd
(Sierra Leone)
Ayrton Drug
Manufacturing
Ltd (Ghana)
100
%
78,57
%
Adcock Ingram
Holdings Limited
2 405
EMPLOYEES
LEVEL 4
B-BBEE
SCORE
BANGALORE
(JV facility)
Capacity: Tablets &
capsules:
3,5 billion units
Accreditations:
UK (MHRA),
Australia (TGA),
South Africa (MCC),
France (ANSES),
Tanzania (TFDA),
Kenya (PPB),
Ghana (FDB),
Namibia (NMRC),
Uganda (UNDA),
Romania
(RNAMMD), and
Ethiopia (FMHACA)
ABOUT US
(continued)
FIVE
SIX
THREE
ONE
FOUR
TWO
| 5
Integrated Report 2016